滋肾清肝方对原发性高血压患者动脉功能及炎症因子的影响
Effects of Zishen Qinggan Formula on Arterial Function and Inflammatory Factors in Patients with Essential Hypertension
-
摘要: 目的 通过观察滋肾清肝方对原发性高血压患者动脉功能及血清炎症因子的影响,评价滋肾清肝方的临床疗效。方法 选择符合纳入标准的原发性高血压患者100例,随机分为治疗组及对照组各50例,治疗组予ACEI/ARB+CCB类药物标准治疗基础上联用滋肾清肝方,对照组予ACEI/ARB+CCB类药物,疗程为8周,对比患者治疗前后中医证候积分、颈动脉内膜中层厚度、极速成像脉搏波传导速度、阻力指数、炎症因子、安全性指标的变化。结果 ①2组中医证候积分治疗后均有改善(P<0.01),且治疗组优于对照组(P<0.01);②双侧颈动脉极速脉搏波传导速度、阻力指数(RI)2组治疗后均有改善(P<0.01),其中治疗组优于对照组(P<0.05),双侧颈动脉内膜中层厚度(IMT)2组治疗前后无明显差异(P>0.05);③2组治疗后血清CRP、IL-6、TNF-α水平均有改善(P<0.05),治疗组优于对照组(P<0.05);④2组治疗前后肝肾功能均无统计学意义(P>0.05)。结论 西药ACEI/ARB+CCB基础治疗联合滋肾清肝方对原发性高血压患者动脉弹性功能及炎症因子的改善优于单用ACEI/ARB+CCB基础治疗。Abstract: OBJECTIVE To evaluate the clinical efficacy of Zishen Qinggan Formula through observing its effects on arterial function and inflammatory factors in patients with essential hypertension. METHODS 100 essential hypertension patients who meet the inclusion criteria were selected and randomly divided into the treatment group and the control group, 50 cases in each group. The treatment group received ACEI/ARB+CCB standard treatment combined with Zishen Qinggan Formula, and the control group received ACEI/ARB+CCB drugs treatment. The course of treatment was 8 weeks. Changes of TCM syndrome scores, carotid intima-media thickness, UltraFast imaging pulse wave velocity (PWV), resistance index, inflammatory factors and safety indexes were compared before and after treatment. RESULTS ①TCM syndrome scores in both groups improved significantly after treatment, and that in the treatment group was better than the control group(P<0.01). ② UltraFast imaging PWV of bilateral carotid arteries and resistance indexes in both groups improved after treatment (P<0.01), among which the treatment group was better than the control group(P<0.05). IMT of bilateral carotid arteries had no difference in two groups before and after treatment (P>0.05). ③ Levels of serum CRP, IL6 and TNFα in both group improved after treatment (P<0.05), and that in the treatment group were better than the control group(P<0.01) ④ There was no significant difference in liver and kidney function in two groups before and after treatment(P>0.05). CONCLUSION In the aspect of improvement of arterial elasticity and inflammatory factors in patients with essential hypertension, western medicine ACEI/ARB+CCB basic therapy combined with Zishen Qinggan Formula is better than ACEI/ARB+CCB basic therapy alone.
-
[1] 吴明竹.对原发性高血压患者进行血清炎症因子TNF-α、IL-6,hs-CRP水平检测的临床价值[J].当代医药论丛,2014,12(9):294-295. [2] WU MZ. Clinical value of levels examination of serum inflammatory factors TNF-α, IL6 and hs-CRP for patients with essential hypertension[J]. Contemp Med Forum, 2014, 12(9): 294-295. [3] MANGGE H, BECKER K. Antioxidants,inflammation and cardiovascular disease[J]. World J Cardiol, 2014, 6(6): 462-477. [4] 王继业,江亚文,刘骏.高血压病患者动脉弹性与动态心电血压的相关性研究[J].中国现代医学杂志,2012,22(14):61-64. [5] WANG JY, JIANG YW, LIU J. Relationship between Ambulatory ECG and Blood Pressure with arterial compliance in essential hypertension patients[J]. Chin J Mod Med, 2012, 22(14): 61-64. [6] NAMBI V, CHAMBLESS L, FOLSOM AR, et al. Carotid intima-media thickness and presence or absence of plaque improves prediction of coronary heart disease risk: the ARIC (Atherosclerosis Risk In Communities) study[J]. J Am Coll Cardiol, 2010, 55(15): 1600-1607. [7] 王燚,赵存瑞,徐鲲,等.高血压病和冠心病患者脉搏波传导速度分析[J].中国动脉硬化杂志,2015,23(10):1026-1030. [8] WANG Y, ZHAO CR, XU K, et al. Analysis of pulse wave velocity in essential hypertension and patients with coronary heart disease[J]. Chin J Arteriosclerosis, 2015, 23(10): 1026-1030. [9] 中华人民共和国卫生部.中药新药临床研究指导原则[M].北京:中国医药科技出版社,2002:73-77. [10] Ministry of Health of the PRC. Guideline for Clinical Trials of New Patent Chinese Medicines[M]. Beijing: China medical science and technology press, 2002: 73-77. [11] 李灿东,吴承玉.中医诊断学[M].北京:中国中医药出版社,2012:200. [12] LI CD, WU CY. TCM Diagnostics[M]. Beijing: China medical science and technology press, 2012: 200. [13] 刘力生.中国高血压病防治指南2010[J].中华高血压杂志,2011,19(8):701-743. [14] LIU LS. Guidelines for the prevention and treatment of hypertension in China 2010[J]. Chin J Hypertension, 2011, 19(8): 701-743. [15] 李婕,方祝元,蒋卫民.炎症因子与原发性高血压的关系及中药干预研究进展[J].江苏中医药,2013, 45(2):76-77. [16] LI J, FANG ZY, JIANG WM. Research progress of relationship between inflammatory factors and essential hypertension and Chinese medicine intervention[J]. Jiangsu J Tradit Chin Med, 2013, 45(2): 76-77. [17] 梅艳,倪淑明,李治国.原发性高血压患者心血管危险因素对动脉弹性的影响[J].中国现代医学杂志,2016,26(2):94-97. [18] MEI Y, NI SM, LI ZG. Influence of cardiovascular risk factors on arterial elasticity in primary hypertensive patients[J]. Chin J Mod Med, 2016, 26(2): 94-97. [19] 陈维杰,樊美红,曲娜.老年高血压患者炎症因子变化与颈动脉粥样硬化的相关性[J].同济大学学报(医学版),2013,34(1):59-61. [20] CHEN WJ, PAN MH, QU N. Relationship between inflammatory factors changes and carotid atherosclerosis in old hypertension patients[J]. J Tongji Univ (Med Sci), 2013, 34(1): 59-61. [21] 王菁哲,余转,魏静,等.原发性高血压患者颈动脉形态学及血流动力学的变化[J].江苏大学学报(医学版),2015, 25(4):339-341. [22] WANG JZ, YU Z, WEI J, et al. Changes of carotid morphology and hemodynamics in patients with essential hypertension[J]. J Jiangsu Univ(Med Sci), 2015, 25(4): 339-341. [23] 黄辉,朱正球,栾云,等.超极速超声成像脉搏波技术在早期颈动脉粥样硬化风险动态评估中的应用价值[J].东南大学学报(医学版),2017,36(1):9-13. [24] HUANG H, ZHU ZQ, LUAN Y, et al. Application of ultrafast ultrasound imaging pulse wave velocity in dynamical indication of early carotid atherosclerosis risk[J]. J Southeast Univ(Med Sci), 2017, 36(1): 913. [25] 孟平平,李东东,朱丹,等.超声极速成像技术评价冠状动脉慢血流患者颈动脉脉搏波传导速度[J].中国医学影像技术,2017,33(1):17-20. [26] MENG PP, LI DD, ZHU D, et al. Ultrasound evaluation of ultrafast imaging in patients with coronary slow flow of carotid pulse wave velocity[J]. Chin J Med Imag Tech, 2017, 33(1): 17-20. [27] 郑梅生,朱琳,郑云菊,等.鲜鬼针草降压作用的实验研究[J].中医临床研究,2016,8(24):16-19. [28] ZHENG MS, ZHU L, ZHENG YJ, et al. Experimental study on the antihypertensive effect of fresh bidens bipinnata L[J]. Clin J Chin Med, 2016, 8(24): 16-19. [29] 周现军.鬼针草抗炎镇痛作用的实验研究[J].四川中医,2008,26(10):62-63. [30] ZHOU XJ. Experimental study on the anti-inflammatory and analgesic effect of Bidens Bipinnata L[J]. J Sichuan Chin Med, 2008, 26(10): 62-63. [31] 丁平,竹剑平.何首乌颗粒治疗高血压病的临床观察[J].浙江中医药大学学报,2009,33(4):493-494. [32] DING P, ZHU JP. Polygonum multiflorum granule treat hypertension[J]. J Zhejiang Chin Med Univ, 2009, 33(4): 493-494. [33] 倪永骋,王晗,张思奇,等.潜阳育阴颗粒对老年高血压患者血压变异性的影响[J].时珍国医国药,2016,27(6):1418-1419. [34] NI YC, WANG H, ZHANG SQ, et al. Effects of Qianyang Yuyin Granule on blood pressure variability in elderly hypertensive patients[J]. Lishizhen Med Mater Med Res, 2016, 27(6): 1418-1419.
点击查看大图
计量
- 文章访问数: 1124
- HTML全文浏览量: 4
- PDF下载量: 1164
- 被引次数: 0